Long-Term Effects of Second-Generation Cholinesterase Inhibitors on Clinical Outcomes and Costs of Alzheimers Disease

ISSN： 1173-8790

Source： Disease Management & Health Outcomes, Vol.11, Iss.10, 2003-01, pp. : 617-631

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-Term Effects of Aerobic Exercise on Psychological Outcomes

By DiLorenzo T.M. Bargman E.P. Stucky-Ropp R. Brassington G.S. Frensch P.A. LaFontaine T.

Preventive Medicine, Vol. 28, Iss. 1, 1999-01 ,pp. : 75-85

Academic Press

Access to resources Recommend Favorite

Short-Term Aggressive Disease Management Programs for Heart Failure: Effect on Drug Utilization, Clinical Outcomes, and Costs

By Kwame O. Akosah Stephanie Carothers

Disease Management & Health Outcomes, Vol. 12, Iss. 4, 2004-01 ,pp. : 221-227

Adis International

Access to resources Recommend Favorite

Spotlight on Galantamine in Alzheimers Disease

By Lyseng-Williamson K.A. Plosker G.L.

Disease Management & Health Outcomes, Vol. 11, Iss. 2, 2003-01 ,pp. : 125-128

Adis International

Access to resources Recommend Favorite

Long-term monitoring of the mortality trend of Huntington’s disease in Austria

By Ekestern Eva Lebhart Gustav

European Journal of Epidemiology, Vol. 20, Iss. 2, 2005-02 ,pp. : 169-172

Springer Publishing Company

Access to resources Recommend Favorite

5 th Conference Clinical Trials on Alzheimer's Disease: October 29-31,2012 Grimaldi Forum, Convention Center, Monte Carlo

The journal of nutrition, health & aging, Vol. 16, Iss. 9, 2012-09 ,pp. : 795-872

Springer Publishing Company

Access to resources Recommend Favorite